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 Nanotechnology meets regenerative medicine: 
a new frontier ? 
 Abstract:  Regenerative medicine is the creation of 
a tissue or organ with normal structures and func-
tions to replace the lost or impaired ones via biologi-
cal modulation and tissue engineering. Indeed, many 
researchers have focused on exploring new techniques 
or approaches in this field. In recent years, numerous 
nanotechnologies have been incorporated into the field 
of regenerative medicine, aiming to replace tissues. The 
application of nanotechnology is important as many 
nanomaterials exhibit novel biological properties in the 
modulation of cellular events. The two main directions 
in this field are to provide biologically compatible scaf-
folds as an optimal environment for cell migration and 
proliferation; as well as to attempt to induce stem cell 
recruitment and differentiation. Thus, this review will 
focus on these two aspects, briefly describing the clinical 
applications. 
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1   Introduction 
 Nanotechnology is defined by the use or the manipula-
tion of materials ranging from 1 to 100    nm  [1] . The rapid 
development of nanotechnology in the past decade has 
resulted in expanding its applications into medical areas 
and has established itself into a new subbranch termed as 
nanomedicine  [2, 3] . At the nanoscale, materials can inter-
act and regulate the cellular/tissue events at the molecu-
lar level. Currently, nanomedicine is leading the way to a 
new perspective and advances in biomedical study and 
clinical application, including diagnostic imaging  [4, 5] , 
anti-inflammation/anti-infection  [6, 7] , cell therapy, and 
nano cryosurgery/laser surgery  [8, 9] , as well as the anti-
cancer drug delivery systems or devices  [10 – 13] . 
 Furthermore, numerous nanotechnologies have also 
been incorporated into the field of regenerative medicine 
in recent years, aiming to replace cells or tissues lost, for 
example, after trauma, ischemic stroke, or myocardial 
infarction  [14] . Indeed, wound repair and regeneration 
occur in any tissue and organs after injury to some extent. 
This is more apparent in the skin in daily life as it is the 
largest organ in the body and has the largest exposed area 
to the outside. The study of tissue repair and healing in 
the skin and bone after wounding plays an essential role 
in advancing knowledge in regenerative medicine. Nano-
technology can contribute to tissue regeneration in various 
ways, involving enhanced cell adhesion and  proliferation/
migration, improvement in growth factor production and 
delivery, provision of scaffold for cell repopulation, as 
well as induction of stem cell differentiation  [15, 16] . This 
review will focus on the use of nanofiber scaffold in tissue 
engineering and nanotechnology- mediated effects on 
stem cells in wound regeneration, as well as their poten-
tial clinical applications. 
2   Regenerative medicine 
 Tissue repair and regeneration are essential biological 
processes during wound healing. Conventional therapy 
for improving tissue repair after injury includes topical 
application of antibacterial drugs, to help maintain a 
relatively clean environment. This would allow the physi-
ological process of healing to take place under normal 
conditions  [17 – 19] . Nonetheless, for large wounds or those 
severe traumas with more tissue defects, the use of con-
ventional therapy has not been universally successful, 
as regeneration of complex structures requires dramatic 
changes in cellular behavior. Many researchers have, 
thus, focused on exploring new techniques or approaches 
to enhance regeneration and function restoration in such 
severe wounds. Indeed, recent studies have shown that 
the promotion of cellular proliferation, migration, and 
differentiation could enable effective repair and regenera-
tion, if used in the appropriate context  [20, 21] . 
 The definition of regenerative medicine is the creation 
of tissue or organ with normal structures and functions 
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to replace the lost or impaired ones via biological and 
tissue engineering  [22] . In this regard, the two main direc-
tions in the development of this field are to provide bio-
logically compatible scaffolds as an optimal environment 
for cell migration and proliferation, as well as to attempt 
to induce stem cell recruitment and differentiation  [23] . 
Recent advances in nanotechnology have been effective in 
incorporating scaffold in tissue engineering and stem cell 
science  [24] , thus, expanding into the realms of regenera-
tive medicine (Figure  1 ). The major applications of various 
nanomaterials currently being used in regenerative medi-
cine are scaffolds, delivery devices, and applications for 
cellular modification. 
3   Nanofiber scaffolds in tissue 
engineering 
 Tissue engineering involves the fabrication of scaffolds 
from synthetic and natural polymers through a variety 
of processing methods to act as biologically active sub-
stitutes for tissues and organs  [25, 26] . Its initial theories 
and techniques of  in vitro tissue constructs have already 
expanded with the development of the incorporation of 
nanotechnology. Indeed, the design and construction of 
the scaffolds are under intensive research in recent years, 
and its basic and important strategy is to construct bio-
compatible scaffolds, in combination with living cells 
and/or bioactive molecules, with the aim to replace, 
regenerate, or repair damaged cells or tissue  [27, 28] . 
 An ideal scaffold should have similar stromal prop-
erties comparable to target tissue. It should also have 
biocompatibility and permeability, controlled porosity, 
as well as support for cell attachment and proliferation. 
In this way, subsequent cell adhesion and growth will be 
greatly enhanced, and thus, acceleration of tissue repair 
and wound regeneration will be prompted. In this regard, 
nanotechnology-derived scaffolds have been proven to 
possess specific physiochemical properties  [29, 30] , sat-
isfactory biocompatibility  [31 – 33] , improved permeabil-
ity  [34, 35] , and adjustable porosity  [36 – 38] . Moreover, 
recent study also indicated that nanotechnology could 
control the scaffold to have better nanotopographies, with 
which the surface roughness would further enhance cell 
attachment and spreading  [39] . Zhu et al. regarded that 
an enlarged surface area of nanostructured materials in 
the scaffold would absorb and attach more adhesive pro-
teins including fibronectin and vitronectin, which would 
increase cell-cell interactions, and tissue regeneration, as 
well as following the repair process in healing  [40] . 
3.1   Biochemical properties of nanofiber 
scaffolds 
 The chemical properties of various nanofiber scaffolds all 
mimic the fibrous architecture of the extracellular matrix 
(ECM) in normal tissues  [41 – 43] . For instance, collagen 
types I, II, III, and IV, as the main ECM in the skin and 
bone tissues, are the most abundant natural polymers in 
the human body (Figure  2 ). They provide cells not only 
with the appropriate microenvironment for growth and 
tissue regeneration but also function to impart structural 
integrity and strength. As a result, collagen has been 
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 Figure 1   Schematic diagram demonstrating multidisciplinary sci-
ences are involved in wound regenerative medicine. The advance 
of nanotechnology further innovates the development of various 
sciences. 
 Figure 2   Masson trichrome of normal skin. Staining showed the 
distribution and density of collagen protein in the skin dermal layer. 
Under this staining, collagen protein was stained blue, the nuclei 
were stained black and background (muscle, cytoplasm and keratin) 
(200 × ). 
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utilized widely to fabricate nanofiber scaffolds. In addi-
tion, other natural polymers, including globular proteins 
and elastin, and synthetic polymers, such as poly (glycolic 
acid) (PGA), poly (lactic acid) (PLA), poly (lactic-co-gly-
colic acid) (PLGA), polydioxanone, and polycaprolactone, 
have also been used  [44] . 
 Regarding the processing of nanofiber scaffolds, 
electrospinning and self-assembly techniques have been 
employed to fabricate for the regeneration of bone, skin, 
cartilage, and cardiac as well as nervous tissues  [45] . 
3.2   Electrospun nanofiber scaffolds 
 Electrospinning is a widely used technique for the pro-
duction of nanofiber scaffolds. It is a controllable tech-
nique through adjusting processing conditions and 
polymer properties. The nanofiber scaffold properties 
can be changed according to the practical requirement, 
especially for the size, porosity, surface topography, bio-
degradability, solubility, and mechanical function. These 
advantages make it possible to modify the spatial align-
ment and orientation, by which cell adhesion and prolif-
eration as well as growth are directed and controlled  [46] . 
 Just like other nanomaterials, the electrospun 
nanofiber scaffolds have larger surface to volume ratio, 
which directly increases the exposure area to the sur-
rounding cells. Therefore, they can be adapted to modu-
late the cellular event to promote proliferation, differ-
entiation, and migration. Meanwhile, the larger area of 
these nanofiber scaffolds also increases the capability 
of cell adhesion. Furthermore, recent studies also indi-
cated that these nanofibers could be also used to deliver 
various drug molecules, genes, and peptides, thus further 
enhancing cell regeneration. 
 During the exploration of the functionalization strate-
gies to improve the delivery efficacy of the nanofiber scaf-
folds, the idea of coelectrospinning of the active surface 
agents and polymers, and the immobilization of bioactive 
ligands, have been sprung  [47] . These could more effec-
tively control the delivery efficacy. Meanwhile, the utiliza-
tion of composites to control the shape of the nanofiber 
scaffolds has also been demonstrated to enhance the deliv-
ery of drug and biomedical properties. In this regard, Zhang 
et al. synthesized electrospinnable bioactive macromole-
cules (collagen and fibronectin) as the shell and a synthetic 
polymer with mechanical and structural properties as the 
core  [48] . This functionalized composite scaffold, on one 
hand, enables cell growth and differentiation; on the other 
hand, the controlled release of encapsulated drugs further 
contributes toward cell regeneration and tissue repair. 
 Sahoo et al. targeted the natural ECM to fabricate into 
electrospun nanofiber scaffolds and deposited  β -fibroblast 
(FB) growth factor, an important growth factor involved in 
mesenchymal stem cell proliferation and differentiation 
in tissue repair. Their study indicated that the electro-
spinning technique could effectively prolong the growth 
factor release from the scaffolds, and a sustained release 
positively influenced the stem cell behavior and fate  [49] . 
Liu et al. further investigated the feasibility of incorporat-
ing neurotrophin-3 and chondroitinase ABC onto the elec-
trospun collagen nanofibers for the treatment of spinal 
cord injuries. Their results showed that it was feasible to 
promote nerve regeneration through the provision of topo-
graphical signals and multiple biochemical cues arising 
from both nanofiber scaffolds and attached cytokines  [50] . 
 The traditional electrospinning technique is mainly 
for the fabrication of the 2-D nanofibrous solution or sheet. 
However, the size of the pores is, in general, too small 
for cell infiltration, resulting in the less protein absorp-
tion and cell adhesion. The seeded cells tend to grow in a 
monolayer on the surface of the mesh  [14] . In recent years, 
research has been focused in producing 3-D nanofiber 
scaffolds for both  in vitro and  in vivo studies and appli-
cations, aiming to improve cell infiltration. Yang et al. 
explored a 3-D multilayered cell-nanofiber scaffold with 
alternating layers of human dermal FBs or keratinocytes 
seeded on PCL/collagen nanofibrous sheets. The results 
indicated that both kinds of cells seeded could effectively 
proliferate and contribute to the formation of new ECM, 
which would indicate the potential to be a substitute of 
the skin  [51] . 
 Horne et al. demonstrated that when compared to the 
classical 2-D cultureware, the modified 3-D electrospun 
poly- ε -caprolactone (PCL) nanofiber scaffolds were more 
superior in enhancing  in vitro proliferation and differen-
tiation of cortical cells. When neurotrophin, brain-derived 
neurotrophic factor (BDNF) were tethered onto the modi-
fied 3-D scaffolds, they further found neural stem cell 
proliferation and differentiation toward neuronal and 
oligodendrocyte lineages, indicating that modified PCL 
nanofiber 3-D scaffolds were capable of supporting neural 
stem cells and their derivatives  [52] . Furthermore, Hurley 
et al. cocultured human microvascular endothelial cells 
(ECs) and FBs in peptide-made 3-D nanofiber scaffolds 
for up to 6   days and found that FBs in scaffolds enhanced 
capillary network formation by improving EC migration 
and increasing vascular endothelial growth factor and 
angiopoietin-1 expression in a temporal manner, while 
EC-FB interactions attenuated FB matrix metalloprotein-
ase-2 expression and increased collagen I deposition, 
resulting in better construct stiffness and a more stable 
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microenvironment in cocultures  [53] . This finding sup-
ported cell-cell interactions, and cell migration in 3-D 
nanoscaffolds contributed to an optimal environment for 
regeneration and tissue repair. 
3.3   Self-assembling nanofiber scaffolds 
 In addition to electrospun nanofiber scaffolds, self-
assembling nanofiber scaffolds provide another intensive 
research target in scaffold fabrication  [54] . When topically 
applied onto the wound, these self-assembling nanofiber 
scaffolds would encourage wound edge tissue contrac-
tion. Furthermore, addition of functional ligands to the 
self-assembling peptides could enhance scaffold self-
assembling effect. 
 Davis et al. designed a self-assembling peptide 
nanofiber scaffold for prolonged delivery of insulin-like 
growth factor 1 (IGF-1), a growth and differentiation factor 
for cardiomyocyte, to the myocardium using a biotin sand-
wich approach. After injection into the rat myocardium, 
the scaffolds provided sustained IGF-1 delivery for 28   days. 
When combined with transplanted cardiomyocytes, IGF-1 
delivery by the scaffolds decreased caspase-3 cleavage 
and increased the myocyte cross-sectional area, through 
which systolic function was improved in an experimental 
myocardial infarction model  [55] . 
 Segers et al. also targeted stromal cell-derived factor-1 
(SDF-1), which is a well-characterized chemokine for 
attracting stem cells and, thus, an ideal candidate for 
promoting regeneration, to investigate the efficacy of 
self-assembling nanofiber scaffolds containing SDF-1 
on myocardial stem cell regeneration. They designed a 
chemokine named S-SDF-1 (S4V) that was resistant to 
matrix metalloproteinase-2 and exopeptidase cleavage 
but retains chemotactic bioactivity, thereby reducing the 
neurotoxic potential of native SDF-1. Self-assembling pep-
tides were used to entrap and deliver S-SDF-1 (S4V). Their 
results demonstrated a nanofiber scaffold-induced deliv-
ery that promoted recruitment of stem cells and improved 
cardiac function in the myocardial infarction area  [56] . 
This suggested that the chemotaxis of stem cells could be 
a promising strategy for tissue regeneration. 
 In addition to the above nanoscaffolds, some protein- 
and peptide-modified synthetic polymeric biomaterials 
were also used for the tissue regeneration and repair, 
including hydrogels based on protein-protein interactions 
and conformational changes of a protein. These conjuga-
tions at nanolevel of polymerics and protein/enzyme, not 
only were used as an ideal delivery system for macromol-
ecules for cell adhesion but also provide a better  “ niche ” 
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 Figure 3   Schematic diagram showing the histological structures 
in the skin. The skin is composed of epidermal and dermal layers 
containing stem cell niches (blue: epidermal stem cells; red: dermal 
mesenchymal stem cells). 
to release important cytokines to local tissues  [57] . Thus, 
these nanomaterials could further promote tissue repair 
due to their protein-protein interactions and conforma-
tional changes of a protein. 
 The 3-D printing technology is another area of inten-
sive research in tissue engineering-mediated regeneration 
and repair. For example, this technology now enables the 
accurate 3-D organization of some components, which 
are important for bone formation, involving graft poros-
ity and vascularization  [58] . In this regard, bone printing 
is regarded as a promising therapeutics in orthopedics 
because it combines rapid prototyping technology to 
produce a scaffold of the desired shape and internal struc-
ture with the incorporation of multiple living cell types 
that can form the bone tissue once implanted  [59] . 
4   Nanomedicine and effects 
on stem cells 
 The biomedical effect of nanoparticles on stem cells in 
wound is another important direction in regenerative 
medi cine. Stem cells exist in most of the tissues and organs 
in the human body, including the skin and bone, cardiac 
tissue, etc. Even after severe injury, a few stem cells can 
still be found remaining in the local environment. These 
can proliferate and, together with the recruitment of the 
circulating stem cells, help in tissue repair. For example, 
in the skin, both the epidermal and dermal layers contain 
a subgroup of stem cells in each layer (Figure  3 ). These epi-
dermal stem cells in the skin include two parts: the epi-
thelial stem cells, found in the epithelial basal layer, and 
the bulge stem cells, located in the hair follicle  [60] . The 
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hair follicle consists of three anatomical structures involv-
ing the outer root sheath, inner root sheath, and hair shaft 
(Figure  4 ), the bulge stem cells are a group of specific cell 
population outer root sheath and have the potential to pro-
liferate and differentiate into keratinocytes after wounding 
 [61, 62] . When the epidermal tissue is damaged, the bulge 
stem cells can migrate to the epidermal layer to differen-
tiate  [63] (Figure  5 ). These populations of stem cells have 
self-renewing potential and amplify rapidly in response to 
skin injury and further undergo several cell divisions for 
the reconstruction of the epidermal barrier  [64, 65] . For the 
dermal mesenchymal stem cells, they have been success-
fully isolated from the mouse and human skin  [66, 67] and 
could be induced to form FBs, cardiomyocytes, adipocytes, 
and neurons  [68, 69] . Furthermore, stem cell grafting is a 
specific technique for those wounds with severe damaged 
tissue or loss. The combination of nanotechnology with 
stem cell science may provide a new therapeutic approach 
for regenerative medicine. 
4.1   Nanoparticles and stem cells 
differentiation 
 Stem cells in the undifferentiated state have the unique 
ability to differentiate into various kinds of cell types and 
the potential to develop into tissues eventually. They can 
be activated under the influence of drug molecules or 
cytokines. For the skin, the epidermal stem cell differen-
tiation toward the keratinocyte lineage will contribute 
to the re-epithelization process during wound regenera-
tion. The underlying signaling mechanisms of skin cell 
regeneration are beginning to be understood. Nguyen 
 Figure 4   HE staining of normal skin hair follicles. Staining showed 
the anatomical structures of transverse section in hair follicles, 
including the outer root sheath (ORS), inner root sheath (IRS), and 
hair shaft (Hs) (400 × ). 
et al. reported that Notch/p63 cross-talk played an essen-
tial role in the differentiation of skin stem cells into 
keratinocytes  [70] . Schafer and Werner found that  c-myc 
knockout mice with the absence of the stem cells in the 
skin epidermal basal layer would display delayed re- 
epithelization  [71] . This would support that  c-myc was a 
regulator of the skin epidermal stem cell fate  [72] . Apart 
from Notch and c-myc, Wnt/ β -catenin  [73, 74] and the 
Hedgehog signaling pathway  [75, 76] have also been impli-
cated in stem cell differentiation during skin regeneration. 
 Some nanoparticles have the potential to promote 
the differentiation of stem cells. For instance, Tian et al. 
reported that the topical application of silver nanoparticles 
(AgNPs) could accelerate healing in a burn wound model 
and that regenerated hair follicle tissue could be observed 
in the granulation tissue in AgNP-treated mice  [77] . This 
finding would suggest that AgNPs might trigger various 
types of skin stem cell differentiations. Following this, we 
also observed a faster differentiation of keratinocytes deriv-
ing from skin stem cells during regeneration  [78] . Moreover, 
others have also observed the concentration-dependent acti-
vation of human mesenchymal stem cells (hMSC) by AgNPs 
 [79] , which suggested that the ECM remodeling process in 
healing could be optimized through the effects of AgNPs, 
with consequent enhancement of the quality of healed skin. 
 For the bone injury, boron-containing compounds 
were shown to have the potential to contribute to osteo-
blast regeneration. Wu et al. explored boron-containing 
mesopore bioactive glass (B-MBG) scaffolds and evaluated 
the response of osteoblasts to these scaffolds. Meanwhile, 
the effect of dexamethasone (DEX) delivery in B-MBG scaf-
fold system on the proliferation, differentiation, and bone-
related gene expression of osteoblasts were also investi-
gated. Their experiment suggested that boron-containing 
nanoparticles promoted osteoblast proliferation and con-
tributed to the DEX release from the MBG scaffolds. Their 
study also suggested that the potential differentiation of 
the MSC induced by this nanoscaffold system into the 
osteoblasts was another factor contributing to bone tissue 
regeneration  [80] . 
4.2   Nanotechnology-based microenvironment 
enhances stem cell differentiation 
 Stem cell niches are the microenvironment to the resident, 
maintenance, and development in cell circle. In recent 
years, intensive research targeted the creation of stem 
cell microenvironment to modulate cellular proliferation, 
differentiation, and maturation. In this regard, studies 
focused on the utilization of nanotechnology to mimic the 
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 in vivo stem cell microenvironment for the investigation of 
the mechanisms underlying the differentiation into differ-
ent cell types  [81] . 
 Silva et al. utilized biologically compatible self-
assembling peptide nanofiber scaffold (SAPNS) to create 
the ECM and used them for the neural cell regeneration. 
They found an effective migration of neural stem cells and 
growth of blood vessels in this scaffold  [82] , which sug-
gested that SAPNS could establish a better 3-D microen-
vironment for the migration and differentiation of stem 
cells. Gelain et al. also reported the development of a 3-D 
cell culture system using the peptide nanofiber scaffold 
with mouse adult neural stem cells. They attached several 
functional motifs to self-assembling peptide RADA16. 
These functionalized peptides underwent self-assembly 
into nanofiber scaffolds similar to matrigel, and cells were 
fully embedded in the 3-D environment of scaffold. The 
results from gene expression profiling array experiments 
showed better neural stem cell adhesion and differentia-
tion  [83] . 
 In recent years, Srouji et al. explored the effects of 
nanoscaffold on hMSC differentiation. It was found that 
this 3-D electrospun porous scaffold (composed of poly 
 ε -caprolactone and collagen) could support hMSC cell 
attachment and proliferation with better distribution. 
When these nanoscaffolds were subcutaneously implanted 
into nude mice, good integration with surrounding tissues 
and neovascularization were seen  [84] . Taken together, the 
combination of nanotechnology and stem cell science will 
bring promise for the wound regenerative medicine. 
4.3   Biological effect of nanotechnology 
on various types of stem cells 
 Nanotechnology-mediated delivery of biomolecules, 
including proteins/enzyme, growth factors, and cytokines 
present an excellent tool to control the differentiation of 
stem cells. Some biocompatible nanoparticles can gain 
access into stem cells and activate signaling cascades. 
 For the embryonic stem cells (ESCs), Ferreira already 
reported that the incorporation of these polymeric nano-
particles had a large impact on the differentiation in the 
human ESCs  [85] . Sridharan et al. explored the use of a 
composite collagen carbon nanotube material as an  in 
vitro cell culture matrix to induce early differentiation of 
human ESC to neural progenitor cells. They used carboxyl-
modified single-walled carbon nanotubes (SWCNTs) to 
obtain a composite material with type I collagen. They 
found that carboxyl-modified SWCNTs contributed to the 
early differentiation of ESCs into neural progenitor cells 
 [86] . Chao et al. found that polyacrylic acid (PAA) grafted 
onto carbon nanotubes has the ability to differentiate 
human ESCs into neurons, and when they grafted a new 
2-D thin film composed of PAA onto the carbon nanotubes, 
they found that the differentiated neurons were more 
mature than those on the pure PAA control surfaces due 
to the lower levels of neural differentiation. Furthermore, 
this new type of thin-film scaffold enhanced ESC prolif-
eration and adhesion  [87] . In the following study, they tar-
geted the ability of PAA-grafted MWCNTs, pure MWCNTs, 
as well as MWCNTs functionalized by polymethacrylic 
Epithelial stem
cell
Sebaceous gland cells
Stem cells in bulge
Matrix cell
DPC
Dermic sheath
ORS
Hair shaft
IRS
 Figure 5   Schematic diagram showing the epidermal stem cell in the skin. Epithelial stem cells and bulge stem cells, respectively, distribute 
in the skin epithelium basal layer and in the outer root sheath in hair follicles (pink: epithelial stem cells; red: bulge stem cells). 
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acid (PMAA) in various differentiation potential of human 
ESCs into neuronal cells  [88] . The results further sug-
gested that carbon nanotubes could enhance cell adhe-
sion and growth factor adsorption, as well as stem cell 
differentiation. In addition to the ESCs, modern regenera-
tive medicine research has been targeting the generation 
of patient-specific induced pluripotent stem cell (iPSC) 
lines  [89] . Indeed, the protocol for the derivation of neural 
crest cells from human iPSCs has been developed  [90, 91] , 
which indicated that these could be induced to differen-
tiate toward the neuron, while nanotechnology will con-
tinue to contribute to the induction and differentiation. 
 For the mesenchymal stem cells, they have the ability 
to differentiate into several specific cell lineages in the 
local microenvironment  [92] . Voge and Stegemann found 
that nanotopography provided by carbon nanotubes 
could influence the mesenchymal stem cell differentiation 
 [93] . Furthermore, the nanofiber scaffold fabricated by the 
electrospinning technique was indicated to be matrix con-
ducive to the differentiation of hMSCs into hepatocyte-like 
cells, and the expression levels of liver-specific markers 
(albumin,  α -fetoprotein) were higher, demonstrating that 
the nanofiber scaffolds enhanced hMSC differentiation 
into a hepatocyte lineage  [94] . Their study suggested that 
the differentiation of mesenchymal stem cells induced by 
nanotechnology might be used in the treatment of liver 
failure. While for the neural stem cell, Kam et al. explored 
the influence of laminin-SWCNTs films on neural stem 
cells, their study indicated that compared with pure 
laminin substrates, laminin-SWCNT films could enhance 
the growth and proliferation of neural stem cells; more-
over, layer-by-layer of films consisting of SWCNTs and 
laminin could promote their adhesion and differentia-
tion, like that of the presence of large amounts of differen-
tiated neurons and glial cells. These results suggested that 
thin composite SWCNT-laminin films can be employed as 
materials in the foundation of neural electrodes to long-
term integration with neural tissue  [95] . 
5   In vivo applications of 
nanotechnologies in 
regenerative medicine 
5.1   Skin tissue regeneration and wound 
dressing 
 For the nanofiber scaffolds, enhanced cell adhesion and 
proliferation due to larger surface, better local adsorption 
of wound liquids due to controllable porosity, and compa-
rability to ECM, make it possible to be used as wound dress-
ing. Meanwhile, these nanofiber scaffolds also have the 
potential to deliver various drug molecules to the wound 
site, which can further contribute to the wound tissue 
regeneration and repair. For example, some nanofiber 
scaffolds could deliver antibiotics  [96 – 99] , some nanopar-
ticles have antibacterial properties  [100 – 102] , and some 
contain cytokines  [103] , as well as growth factors  [104] . 
Khil et al. initially explored the coating of polyurethane 
membrane on wound dressing using electrospun nanofi-
brous technique. Their study indicated that this wound 
dressing led to an increased rate of epithelialization and 
dermis organization in wound tissue  [105] . In a subse-
quent study, Chen and Chiang modified the polyurethane 
membrane by adding AgNPs  [106] . The polyurethane 
membrane ’ s antimicrobial activity improved to approxi-
mately 100 % and suggested that this modified product 
was a better collagen sponge wound dressing. 
 In theory, any polymer with better biocompat-
ibility and antibacterial properties can be conjugated to 
nanofiber scaffolds for the fabrication of wound dressing. 
For instance, chitosan is a natural biodegradable polymer 
with ideal biocompatibility, antibacterial, hemostatic, 
as well as wound-healing properties  [106, 107] . Meng 
et al. found an improved healing of deep second-degree 
burns in rats using wound dressing coated with RADA16-I 
peptide self-assembling nanofiber hydrogel scaffolds 
 [108] . Zhou et al. used electrospun carboxyethyl chitosan/
polyvinyl alcohol to construct wound dressing and found 
that the electrospun matrix could be used as a potential 
wound dressing for skin regeneration  [109] . This finding 
was further supported by the Kang et al. study  [110] . Other 
candidates for wound dressing applications include silk 
fibroin/hydroxybutyl chitosan nanofibrous scaffolds. 
They have also been shown to have a good biocompatibil-
ity with better cell viability and fast skin wound healing 
rate  [111, 112] . 
5.2   Bone regeneration 
 Bone is a mineralized organic matrix composed of col-
lagenous fibers and calcium phosphate and exists in the 
format of hydroxyapatite (HA). A large amount of osteo-
blasts, osteocytes, and osteoclasts are embedded in the 
bone tissue, which is endowed with both elasticity and 
hardness. Therefore, in terms of designing the bone scaf-
folds in reconstruction, several factors need to be con-
sidered. These include suitable biophysical properties 
(elastics and hardness), porosity to support cell growth, 
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and differentiation  [14] . Furthermore, for those nanoscaf-
folds with delivery function, the releasing kinetics of 
drug molecules from scaffolds and sustainability of cel-
lular differentiation also need to be considered. In this 
regard, osteoblast ossification induced by nanofiber 
scaffolds has been investigated in various HA compos-
ites, including with collagen  [113 – 115] , PLA  [116] , and 
PLGA  [117, 118] . Furthermore, Gentile and Zou explored 
HA/gelatin composite nanoscaffolds in both  in vitro and 
 in vivo experiments and found that these nanoscaffolds 
could effectively promote osteoblast proliferation and 
adhesion, and the ossification process was accelerated 
 [119, 120] . 
 Li et al. targeted silk fibroin fiber scaffolds contain-
ing bone morphogenetic protein 2 (BMP-2) to explore 
the effect on hMSCs. They found that the scaffold could 
support hMSC growth and differentiation toward osteo-
cytic lineage. Enhanced calcium deposition  in vitro and 
upregulation of the transcript levels of bone-specific 
markers were demonstrated, indicating that these scaf-
folds provided an efficient delivery device for BMP-2 and 
induced improved bone formation  [121] . 
5.3   Neural tissue regeneration 
 Ellis-Behnke et al. initially explored the effect of self-
assembling peptide nanofiber scaffold on the repair of 
injured brain tissue. They found in a hamster model 
of severed optic tract that the nanofiber scaffold could 
enhance regenerated axon reconnection to target tissues 
with sufficient density to promote functional return of 
vision, indicating that the nanofiber scaffold could con-
tribute to tissue repair and restoration, and would be 
helpful to the central nervous system trauma  [122] . Wang 
et al. fabricated the chitosan nano/microfiber mesh tubes 
with a deacetylation rate (DAc) of 93 % and used them 
to bridge injured rat sciatic nerve, observed sufficient 
mechanical properties to preserve tube space and provi-
sion of a better scaffold for cell migration and attachment, 
and enhanced nerve regeneration  [34] , which further pro-
vided the evidence that nanofiber scaffold had the poten-
tial for the therapy of severe regeneration. 
 In recent years, Sakai et al. found that conduits 
reconstructed using hyaluronic acid (HA) had better 
cell adhesion and differentiation, through the contribu-
tion from axonal regeneration in the peripheral nerves 
 [123] . Ding et al. also targeted the rabbit sciatic nerves 
damaged model to explore the tissue-engineered scaf-
fold-mediated regenerative effect, and they found supe-
rior functionality of the nanosilver-collagen scaffold in 
the adsorption to laminin and subsequent regeneration 
of damaged sciatic nerves  [124] . 
5.4   Cardiac tissue regeneration 
 Cell-based therapies in cardiac tissue engineering repre-
sent a potential cure for patients with cardiac diseases, 
including myocardial infarction and heart failure. Cur-
rently, stem cell science has started to play an essential 
role in cardiac tissue regeneration and repair. Various 
stem cell graftings, including iPSC immobilization for 
myocardial infarction (MI) therapy, have achieved satis-
factory efficacy. 
 Initially, it was found that injection of human ESC-
derived vascular cells in a bioactive hydrogel could form 
capillaries in the infarcted zone in a rat model  [125] . In 
this regard, Caspi et al. have engineered vascularized 
cardiac muscle using hESC-derived cardiomyocytes and 
hESC-derived ECs, and increased cardiomyocyte and EC 
proliferation, as well as the formation of vessel-like struc-
tures could be observed in engineered tissues  [126] . Cur-
rently, iPS cells have been shown to be promising for use 
in cardiac tissue-engineering strategies, as they can give 
rise to functional cardiomyocytes  [127] . The use of iPS cells 
would not only overcome the ethical concerns related to 
the use of hESCs, but it might also allow for the genera-
tion of an unlimited supply of functional, proliferative, 
and possibly autologous human cardiomyocytes and vas-
cular cells, thus, overcoming any immunogenic concerns 
as well  [128] . 
6   Conclusions 
 The advance of nanotechnology and its incorporation into 
other sciences, have greatly contributed to the progress of 
regenerative medicine, especially in controlling stem cell 
differentiation, modification of biocompatible materials, 
and the enhancement of drug delivery. Current interest 
of nanotechnology in the regenerative medicine field is 
growing at a great pace due to its capacity to mimic natural 
tissues. In the future, nanotechnology will be even more 
reliable, stable, and imaginative. Nonetheless, the nano-
materials used should be natural, non-immunogenic, and 
nontoxic. Before translating the findings of basic labora-
tory study to clinical trials, comprehensive assessment on 
the potential toxicity and side effects should be taken to 
ensure the absolute safety of our patients. 
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